TB
Trailhead Biosystems Inc.
SEC filingBiotechnology · Beachwood, OH
Amount raised$40.4Msold at filing
Total offering$40.4M
Investors in the raise7count reported to the SEC
FiledJul 30, 2026first sale Jun 21, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Houman HemmatiDirector
Wolfgang HofmannDirector
Craig NemiroffExecutive Officer
David LlewellynExecutive Officer, Director
Joshua SnowExecutive Officer
Jan JensenDirector
Divya TrivediExecutive Officer
Michael KaufmanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.